ondansetron has been researched along with Amaurosis in 3 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Excerpt | Relevance | Reference |
---|---|---|
"Progressive encephalopathy and partial loss of vision were the main observed signs." | 2.39 | Subacute encephalopathic toxicity of cisplatin. ( Conrad, CA; Hong, WK; Verschraegen, C, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Perry, JD | 1 |
Cherian, A | 1 |
Maguire, M | 1 |
Verschraegen, C | 1 |
Conrad, CA | 1 |
Hong, WK | 1 |
1 review available for ondansetron and Amaurosis
Article | Year |
---|---|
Subacute encephalopathic toxicity of cisplatin.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blindness; Brain Diseases; Ci | 1995 |
2 other studies available for ondansetron and Amaurosis
Article | Year |
---|---|
Letter to the editor regarding article, "A challenging problem that concerns the aesthetic surgeon".
Topics: Antiemetics; Blindness; Eye Hemorrhage; Humans; Ondansetron; Postoperative Nausea and Vomiting | 2009 |
Transient blindness following intravenous ondansetron.
Topics: Adult; Antiemetics; Blindness; Female; Humans; Ondansetron; Postoperative Complications; Postoperati | 2005 |